These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 17212147)

  • 1. [Successful treatment for intractable ascites with uterine cancer using double Denver peritoneovenous shunt system].
    Kawamoto J; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1919-23. PubMed ID: 17212147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts.
    Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Nakao A; Soda M; Shimizu N
    Anticancer Res; 2006; 26(3B):2393-5. PubMed ID: 16821622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative treatment of malignant refractory ascites by positioning of Denver peritoneovenous shunt.
    Zanon C; Grosso M; Aprà F; Clara R; Bortolini M; Quaglino F; Cornaglia S; Simone P
    Tumori; 2002; 88(2):123-7. PubMed ID: 12088251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Denver type for peritoneovenous shunting of malignant ascites.
    Roussel JG; Kroon BB; Hart GA
    Surg Gynecol Obstet; 1986 Mar; 162(3):235-40. PubMed ID: 2420017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Percutaneous implant of Denver peritoneovenous shunt: a new opportunity for the interventional radiologist].
    Spreafico C; Patelli G; Lanocita R; Di Tolla G; Marchianò A; Frigerio L; Garbagnati F; Ticha V; Damascelli B
    Radiol Med; 2001 Sep; 102(3):154-8. PubMed ID: 11677458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation of a Denver shunt by left subclavian approach for preventing kinking.
    Oida T; Mimatsu K; Kawasaki A; Kanou H; Kuboi Y; Matsuoka S; Amano S
    Hepatogastroenterology; 2009; 56(93):1074-7. PubMed ID: 19760944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peritovenous shunt (Denver Shunt) in therapy resistant ascites in childhood].
    Teufel M; Reifferscheid P; Niessen KH
    Monatsschr Kinderheilkd; 1983 Sep; 131(9):603-6. PubMed ID: 6621573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneovenous shunting for malignant ascites.
    Wickremesekera SK; Stubbs RS
    N Z Med J; 1997 Feb; 110(1037):33-5. PubMed ID: 9066565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneovenous shunt for palliation of gynecologic malignant ascites.
    Faught W; Kirkpatrick JR; Krepart GV; Heywood MS; Lotocki RJ
    J Am Coll Surg; 1995 Apr; 180(4):472-4. PubMed ID: 7536598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneovenous shunt in malignant ascites. The Bordet Institute experience from 1975-1998.
    Tueche SG; Pector JC
    Hepatogastroenterology; 2000; 47(35):1322-4. PubMed ID: 11100342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of neonatal chylous ascites using a modified Denver peritoneovenous shunt: a case report.
    Camoglio FS; Dipaola G; Cervellione RM; Chironi C; Giacomello L; Zanatta C; Ottolenghi A
    Pediatr Med Chir; 2003; 25(2):145-7. PubMed ID: 12916444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Our experiences with saphenoperitoneal shunts in the treatment of intractable ascites.
    Vizsy L; Beznicza H; Batorfi J
    Hepatogastroenterology; 2005; 52(63):920-2. PubMed ID: 15966232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneovenous shunting in intractable ascites.
    Deans GT; Spence RA; Johnston GW
    Ulster Med J; 1985 Oct; 54(2):155-9. PubMed ID: 4095803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of the peritoneovenous shunt for the management of intractable ascites.
    Fry PD; Hallgren R; Robertson ME
    Can J Surg; 1979 Nov; 22(6):557-9. PubMed ID: 497929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphangiomyomatosis with chylous ascites treatment successfully by peritoneo-venous shunting].
    Kimura M; Morikawa T; Takeuchi K; Furuie H; Fukimura M; Mikami R; Kakuta Y; Kawamura S; Tashiro Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 May; 34(5):557-62. PubMed ID: 8753114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Denver shunt in malignant ascites].
    Van Damme H; Vaneerdeweg W; Schoofs E
    Acta Chir Belg; 1985; 85(1):43-52. PubMed ID: 2580408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic results of Denver percutaneous peritoneovenous shunt in cancer patients with malignant ascites.
    Tamagawa H; Aoyama T; Inoue H; Fujikawa H; Sawazaki S; Numata M; Sato T; Oshima T; Yukawa N; Morimoto M; Ueno M; Rino Y; Masuda M
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S95-S98. PubMed ID: 33380660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.